Skip to content

Effect of transcutaneous auricular vagus nerve stimulation (taVNS) on postoperative pain in patients undergoing laparoscopic total hysterectomy

Effect of transcutaneous auricular vagus nerve stimulation (taVNS) on postoperative pain in patients undergoing laparoscopic total hysterectomy

Status
Active, not recruiting
Phases
Early Phase 1
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR2400080780
Enrollment
Unknown
Registered
2024-02-07
Start date
2024-02-10
Completion date
Unknown
Last updated
2024-02-11

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

laparoscopic total hysterectomy

Interventions

General anesthesia + taVNS group:Electrode sheets were placed in the distribution area of bilateral ear vagus nerves (auricular nail), and the stimulation was maintained with appropriate current and f
the electrode sheets were placed at 24 h after the operation and the stimulation was continued for 30 min using the same current, and the stimulation was performed twice in total.
General anesthesia + sham taVNS group:Electrode slices were placed in the area of bilateral ear vagus nerve distribution (auricular nail), and electrode slices were placed at the beginning of the proc

Sponsors

The First Affiliated Hospital of Gannan Medical College
Lead Sponsor

Eligibility

Sex/Gender
Female
Age
18 Years to 60 Years

Inclusion criteria

Inclusion criteria: 1.The patients were all laparoscopic total hysterectomies, aged 18-60 years and; 2.ASA class I-II; 3.BMI 18.5-28.0 kg/m²; 4.The patients and their families agreed to conduct this study and had signed an informed consent form.

Exclusion criteria

Exclusion criteria: 1.Declined to participate in this study; 2.Already participating in other clinical studies; 3.Broken, red, swollen, infected skin at the site of the proposed transcutaneous electrical stimulation of the ear vagus nerve; 4.Patients with severe systemic diseases; 5.History of recent or routine acupuncture treatment; 6.History of alcohol, drug dependence or drug use; 7.Participants unable to cooperate for reasons such as communication disorders; 8.Presence of potential medical problems with receiving transcutaneous auricular vagus nerve stimulation (taVNS): e.g., those with pacemakers or metal implants or allergies to surface electrodes

Design outcomes

Primary

MeasureTime frame
Visual analog scoring ,VAS;

Secondary

MeasureTime frame
Mean arterial pressure;heart rate;Quality of Recovery Rating Scale (QoR-40 scale) score at 24 h postoperatively;Number of PCIA single presses in postoperative patients;Additional doses of remedial analgesic drugs for postoperative patients;Intraoperative anesthesia dosage;Surgical time and tracheal extubation time;Occurrence of adverse reactions;

Countries

China

Contacts

Public ContactYE Jun-ming

The First Affiliated Hospital of Gannan Medical College

yjm7798@sina.com+86 137 0797 9175

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026